Evidence map›Paper›PMID 26837704›Full record

ArticleScientific reports2016

Omics for prediction of environmental health effects: Blood leukocyte-based cross-omic profiling reliably predicts diseases associated with tobacco smoking.

Panagiotis Georgiadis, Dennie G Hebels, Ioannis Valavanis, Irene Liampa, Ingvar A Bergdahl, Anders Johansson, Domenico Palli, Marc Chadeau-Hyam, Aristotelis Chatziioannou, Danyel G J Jennen and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 41 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Age-Related Differences in miRNA Expression in Mexican-American Newborns and Children.International journal of environmental research and public health · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 12 institutions in 8 countries.

Panagiotis GeorgiadisNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Dennie G HebelsMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Ioannis ValavanisNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Irene LiampaNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Ingvar A BergdahlDepartment of Biobank Research, and Occupational and Environmental Medicine, Department of Public Health and Clinical Medicine, Umeå University, Sweden.
Anders JohanssonNutrition Research, Department of Public Health and Clinical Medicine, Umeå University, Sweden.
Domenico PalliThe Institute for Cancer Research and Prevention, Italy.
Marc Chadeau-HyamMRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, W2 1PG, UK.
Aristotelis ChatziioannouNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
Danyel G J JennenMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Julian KrauskopfMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Marlon J JettenMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Jos C S KleinjansMaastricht University, Minderbroedersberg 4-6, 6211 LK, Maastricht, Netherlands.
Paolo VineisMRC-PHE Centre for Environment and Health, Department of Epidemiology and Biostatistics, School of Public Health, Faculty of Medicine, Imperial College London, St Mary's Campus, Norfolk Place, W2 1PG, UK.
Soterios A KyrtopoulosNational Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, 48 Vas. Constantinou Ave., Athens 11635, Greece.
EnviroGenomarkers consortium
Maastricht University · NLNational Taiwan University · TWImperial College London · GBNational Hellenic Research Foundation · GRUmeå University · SEFinnish Institute for Health and Welfare · FIUniversity of Leeds · GBIstituto Superiore di Sanità · ITUtrecht University · NLLund University · SEUniversity of Crete · GRCenter for Research in Environmental Epidemiology · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The utility of blood-based omic profiles for linking environmental exposures to their potential health effects was evaluated in 649 individuals, drawn from the general population, in relation to tobacco smoking, an exposure with well-characterised health effects. Using disease connectivity analysis, we found that the combination of smoking-modified, genome-wide gene (including miRNA) expression and DNA methylation profiles predicts with remarkable reliability most diseases and conditions independently known to be causally associated with smoking (indicative estimates of sensitivity and positive predictive value 94% and 84%, respectively). Bioinformatics analysis reveals the importance of a small number of smoking-modified, master-regulatory genes and suggest a central role for altered ubiquitination. The smoking-induced gene expression profiles overlap significantly with profiles present in blood cells of patients with lung cancer or coronary heart disease, diseases strongly associated with tobacco smoking. These results provide proof-of-principle support to the suggestion that omic profiling in peripheral blood has the potential of identifying early, disease-related perturbations caused by toxic exposures and may be a useful tool in hazard and risk assessment.

Indexed as

DNA MethylationComputational BiologyCoronary Artery DiseaseEnvironmental ExposureEnvironmental HealthFemaleGene Expression ProfilingGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansLung NeoplasmsMaleMiddle AgedSmoking

Identifiers

PMID26837704
PMCPMC4738297
OpenAlexW2299377942

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.